Release Date: 04/02/16 16:37 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 195.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%